Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation-Reference-Cited by-同舟云学术

Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation

Published:2013-07-17 Issue:12 Volume:15 Page:1805-1811
ISSN:1099-5129
Container-title:Europace
language:en
Short-container-title:Europace

Author:

Delannoy E.,Sacher F.,Maury P.,Mabo P.,Mansourati J.,Magnin I.,Camous J.-P.,Tournant G.,Rendu E.,Kyndt F.,Haissaguerre M.,Bezieau S.,Guyomarch B.,Le Marec H.,Fressart V.,Denjoy I.,Probst V.

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/europace/article-pdf/15/12/1805/7278705/eut160.pdf

Reference25 articles.

1. INTERMITTENT MUSCULAR WEAKNESS, EXTRASYSTOLES, AND MULTIPLE DEVELOPMENTAL ANOMALIES.

2. Mutations in Kir2.1 Cause the Developmental and Episodic Electrical Phenotypes of Andersen's Syndrome

3. PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-Faceted Approach to Ventricular Tachycardia: A Review of Management Strategies;Pharmacoepidemiology;2024-08-12

2. Management of ultrarare inherited arrhythmia syndromes;Heart Rhythm;2024-08

3. Contributions of France to the field of clinical cardiac electrophysiology and pacing;Heart Rhythm O2;2024-07

4. Kir2.1-NaV1.5 channelosome and its role in arrhythmias in inheritable cardiac diseases;Heart Rhythm;2024-05

5. The network of cardiac KIR2.1: its function, cellular regulation, electrical signaling, diseases and new drug avenues;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-04-29